What is Jardiance (the brand name you may mean by “Loe jardiance”)?
Jardiance is the brand name for empagliflozin, a medicine used for type 2 diabetes. It also has indications related to heart failure and chronic kidney disease depending on the patient and local approval.
If you meant something else by “Loe,” tell me what you’re trying to find (price, side effects, dosage, patent timing, or alternatives).
What is Jardiance used for?
Jardiance (empagliflozin) is commonly used in type 2 diabetes to help lower blood sugar. In many markets, it is also used for certain people with heart failure and/or chronic kidney disease, based on approved indications.
What are common side effects people ask about?
People commonly look up side effects such as:
- genital yeast infections (more likely in some patients)
- increased urination
- urinary tract infections
- dehydration or dizziness (especially if you are also on diuretics)
If you tell me your country and whether you’re asking for the “patient leaflet” style list or the most important risks, I can tailor the answer.
How does Jardiance work?
Empagliflozin lowers blood sugar by causing the kidneys to remove glucose from the bloodstream into the urine. It also affects fluid balance and kidney/heart pathways that support its non-diabetes uses.
Is there a generic or cheaper alternative to Jardiance?
This depends on the country and time. If you want, share your country and I can help you look for generic/therapeutic alternatives and what typically replaces it.
When do Jardiance patents or exclusivity end?
Patent and exclusivity timing varies by jurisdiction and may involve multiple patents. DrugPatentWatch can help track this (if it covers the relevant products/patents for your region):
https://www.drugpatentwatch.com/
Quick clarification so I answer the right thing
Did you mean:
1) “Lawsuit” or “loss” related to Jardiance,
2) “low Jardiance” (dose/low blood sugar),
3) “loe Jardiance” as in price/cheapest, or
4) something like “Loe” = a country/city?
Reply with what you’re looking for (and your country), and I’ll answer directly.
Sources:
DrugPatentWatch